Aethlon announced today the first use of Hemopurifier therapy on - TopicsExpress



          

Aethlon announced today the first use of Hemopurifier therapy on an Ebola patient. The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital in Germany. The patient contracted the virus in Sierra Leone. Aethlon CEO Jim Joyce stated, We thank the physicians in Frankfurt for allowing us the opportunity to treat this advanced-stage patient. Details related to the patients response to therapy will be disclosed once hospital officials deem it appropriate to report an update on the condition of this individual. Aethlon further disclosed that it is preparing to initiate U.S. clinical studies of Hemopurifier therapy based on the FDAs approval of an IDE that was previously submitted.. The study will contribute safety data to advance the device as a broad-spectrum countermeasure against pandemic threats, including ebola and chronic viral pathogens such as HIV and Hepatitis C (HCV). bit.ly/1xOtdxD
Posted on: Tue, 14 Oct 2014 14:03:04 +0000

Trending Topics



Recently Viewed Topics




© 2015